162 related articles for article (PubMed ID: 10541284)
1. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line.
Ferguson S; Hébert RL; Laneuville O
J Am Soc Nephrol; 1999 Nov; 10(11):2261-71. PubMed ID: 10541284
[TBL] [Abstract][Full Text] [Related]
2. Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells.
Nasrallah R; Laneuville O; Ferguson S; Hébert RL
Am J Physiol Renal Physiol; 2001 Jul; 281(1):F123-32. PubMed ID: 11399653
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development.
Kömhoff M; Wang JL; Cheng HF; Langenbach R; McKanna JA; Harris RC; Breyer MD
Kidney Int; 2000 Feb; 57(2):414-22. PubMed ID: 10652018
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
6. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
Rozic JG; Chakraborty C; Lala PK
Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
[TBL] [Abstract][Full Text] [Related]
9. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells.
Noguchi K; Shitashige M; Ishikawa I
J Periodontol; 1999 Aug; 70(8):902-8. PubMed ID: 10476899
[TBL] [Abstract][Full Text] [Related]
11. Induction of COX-2 expression by mechanical tension force in human periodontal ligament cells.
Shimizu N; Ozawa Y; Yamaguchi M; Goseki T; Ohzeki K; Abiko Y
J Periodontol; 1998 Jun; 69(6):670-7. PubMed ID: 9660336
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
Elder DJ; Halton DE; Crew TE; Paraskeva C
Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
[TBL] [Abstract][Full Text] [Related]
15. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
16. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.
Kim TI; Lee YC; Lee KH; Han JH; Chon CY; Moon YM; Kang JK; Park IS
Infect Immun; 2001 Aug; 69(8):5056-63. PubMed ID: 11447186
[TBL] [Abstract][Full Text] [Related]
17. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
Xu H; Izon DJ; Loftin C; Spain LM
Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
19. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 is upregulated in inflamed gingival tissues.
Morton RS; Dongari-Bagtzoglou AI
J Periodontol; 2001 Apr; 72(4):461-9. PubMed ID: 11338298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
